Clinic
City of Abilene
City of Abilene was paid $230K by Medicaid between Jul 2018 and Dec 2024, across 45 billing codes. Its largest line is J1050, Injection, medroxyprogesterone acetate, 1 mg — 19% of everything it billed.
33Billing provider infoCITY OF ABILENE
ABILENE, TX 79601
ABILENE, TX 79601
33aNPI1427015163assigned 04/27/2006
33bProvider typeAmbulatory Family Planning Facility
28Total paid$230K
24GClaims16,180
24DCodes billed45
24AFirst – last monthJul 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Family Planning Facility providers in Texas
Rank by total paid#30 of 73
Median peer was paid$144K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 488 | $3K | |
| 2019 | 593 | $3K | |
| 2020 | 1,508 | $34K | |
| 2021 | 2,464 | $39K | |
| 2022 | 4,163 | $64K | |
| 2023 | 3,989 | $53K | |
| 2024incomplete | 2,975 | $33K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 19% | 648 | 614 | $44K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 18% | 721 | 710 | $41K |
| 99000 | 9.5% | 2,391 | 2,271 | $22K | |
| S4993 | Contraceptive pills for birth control | 9.2% | 231 | 225 | $21K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 8.2% | 2,152 | 1,939 | $19K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 8.1% | 2,629 | 1,169 | $19K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.2% | 662 | 631 | $17K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 6.2% | 229 | 229 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.8% | 783 | 760 | $9K |
| 99385 | 2.6% | 91 | 91 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.9% | 74 | 65 | $4K |
| 81025 | 1.4% | 593 | 558 | $3K |
33 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 271 | $3K |
| 81003 | 1.1% | 1,862 | $2K | |
| 90651 | <1% | 205 | $2K | |
| 99001 | <1% | 154 | $841.59 | |
| 87210 | <1% | 115 | $537.90 | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 57 | $499.16 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 27 | $453.87 |
| 81000 | <1% | 124 | $412.36 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $384.27 |
| 81002 | <1% | 109 | $286.16 | |
| 90713 | <1% | 199 | $87.04 | |
| 90715 | <1% | 256 | $65.28 | |
| 86780 | <1% | 45 | $20.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 59 | $20.00 |
| 90734 | <1% | 283 | $13.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 59 | $10.00 |
| 86762 | <1% | 30 | $10.00 | |
| 85027 | <1% | 36 | $5.43 | |
| 90686 | <1% | 168 | $4.01 | |
| 90633 | 0% | 338 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 17 | $0.00 |
| 90700 | 0% | 14 | $0.00 | |
| 80061 | Lipid panel | 0% | 14 | $0.00 |
| 90707 | 0% | 14 | $0.00 | |
| 90716 | 0% | 213 | $0.00 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 0% | 60 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 14 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 13 | $0.00 |
| 90619 | 0% | 64 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 93 | $0.00 |
| 90677 | 0% | 21 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 14 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLERMA, ANNETTE (DIRECTOR OF PUBLIC HEALTH)